DATA ENABLES PHARMA 4.0
With the advancement of Pharma 4.0, there is the potential to implement significant business improvements using digital tools and capabilities. The availability of technologies, such as cloud-based platforms, artificial intelligence (AI), machine learning (ML), advanced process analytics, etc., enables drug manufacturers to better understand, monitor, and control their production processes. However, these technologies are simply tools and a thorough understanding of specific applications and use cases is an absolute necessity in selecting and implementing the right technologies for a particular situation.
THE RIGHT DATA AT THE RIGHT TIME
The common denominator for effective application of Pharma 4.0 technologies is having access to the critical data when it is needed for the specific process. If, in order to drive time sensitive actions or process control adjustments, an application requires real-time access to the data, then the system architecture and data flow needs to be set-up to support this access. However, if the data is being used retroactively, such as in trending analysis applications, then the data can be collected, stored, and used when needed by key users. Electronic data or eData provides the vehicle for ensuring that the critical data required for an application is easily accessible and available when needed for a specific process. Identification of the data requirements, the required granularity levels, necessary data integrity measures, data consistency and mapping, etc., should be addressed during the overall technology platform architecture development and implementation phases.
Login now to read the full article
Don’t have an account yet? Subscribe now, it’s free!
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt.
All pubblications
archive from 2022 to today
All articles
PDF Version
Receive our latest issue alerts
directly to your mailbox
